Published on in Vol 10 (2024)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/54429, first published
.

Journals
- Kumar A, Mazumdar A, Bhattacharjee A, Gupta A, Dasgupta A, Sinha B, Saboo B, Selvan C, Goyal G, Balaji J, Seshadri K, Gangopadhyay K, Kumar G, Chawla M, Sikdar M, Deka N, Singh N, Chawla P, Jetwani P, Kovil R, Ghosal S, Ray S, Chatterjee S, Chandrasekharan S, Das S, Ghosh S, Patange S, Reddy S, Surekha T. Risk factors associated with Indian type 2 diabetes patients with chronic kidney disease: CITE study, a cross-sectional, real-world, observational study. BMC Nephrology 2025;26(1) View
- Li D, Feng P, Wang Y, Yang J. Exosomes applications in kidney diseases. Molecular Biology Reports 2025;52(1) View
- Yu J, Luo F, Zhang Y, Yang J, Yu S, Li N, Yang A, Ma L, Li J. The global incidence rate of type 2 diabetes related chronic kidney disease and predictions by Bayesian age-period-cohort analysis: findings from the Global Burden of Disease Study 2019. Frontiers in Endocrinology 2025;16 View
- Fang Y, Jing L, Zhu Y, Wang H, Xia J, Lei T, Lu J, Gao J. Relationship between flow-mediated dilation and urinary albumin-creatinine ratio in patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications 2025;39(10):109162 View
- Li Z, Yang S, Zhou X, Qing Y, Zhang T, Xu W, Duan W, Ren F, Deng H, Wang W, Li M, Feng M, Rao C. Alterations in gut–kidney axis indicators and TMAO-related biomarkers in elderly patients with hypertensive nephropathy. Frontiers in Medicine 2025;12 View
- Thapa K, Kanojia N, Khan H, Kaur A, Singh T. Angiopoietins: A potential therapeutic target in the treatment of diabetic nephropathy. Obesity Medicine 2025;58:100659 View
- Zhan L, Zhu S, Ding Z, Guo B, Deng X, Wu B, Yang Z, Guo M, Fan Y. Patient expectations and concerns regarding robotic thyroidectomy in china: a cross-sectional study. Journal of Robotic Surgery 2025;19(1) View
- Pan Z, Li M, Zhang J, Xue L, Shi Y. Correlation of gut microbiota metabolite trimethylamine N-oxide with inflammatory levels and osteoporosis in patients with diabetic nephropathy. World Journal of Diabetes 2025;16(11) View
- Raza S, Rehman A, Aamir A, Qureshi F, Sajid A, Waseem T, Abbasi M, Farooq F, Sachdewani R, Raja U, Akram J, Syed U, Iqtadar S, Nabi Z, Mand A, Mal P, Shah S, Mohsin A, Mohydin B, Sheikh A, Rizwan A, Mushtaq M. Comparative efficacy and safety of finerenone in diabetic kidney disease: a meta-analysis of Asian and non-Asian populations. BMC Nephrology 2025;26(1) View
- Wang Y, Wang Y, Mu Y, Cheng Y. Effects of SGLT2 inhibitors on development and progression of kidney disease in Chinese patients with type 2 diabetes: A multicentre, prospective real‐world study. Diabetes, Obesity and Metabolism 2025 View
- Shang X, Sun S, Jiang S, Deng Z, Wang S, Lu J, Li W. Geographical differences in the prevalence of diabetic kidney disease in middle-aged and elderly patients in China: an analysis based on the Bayesian conditional autoregressive model. BMC Nephrology 2026 View
